Coralville firm to file $58 million IPO

Coralville firm to file $58 million IPO

/wp-content/uploads/2022/11/BR_web_311x311.jpeg

BPC Staff | Mar 16, 2015 | 4:08 pm |

<1 min read time

KemPharm, a Coralville-based firm that is developing an abuse-deterrent version of Vicodin, has filed with the U.S. Securities and Exchange Commission its plans to raise up to $58 million in an initial public offering, Renaissance Capital reported in an article picked up by NASDAQ. The company, founded in 2006, will be traded on the Nasdaq Stock Market under the symbol KMPH. Cowen & Co. and RBC Capital Markets are the joint bookrunners on the deal. No pricing terms were disclosed.